If you would like to submit a blog post for consideration, please email firstname.lastname@example.org
[Podcast] Imiquimod for BCC
In this latest podcast, Prof David Wilkinson (Chief Medical Officer of National Skin Cancer Centres) speaks with Dr Yevgeny (Gene) Filanovsky (a Family Physician with Cutaneous Surgery and Skin Cancer Focus at Skin Care West, Canada) about how he uses imiquimod in his practice for the treatment of BCC.
Listen to the full podcast now:
For further information on this topic, you may be interested to learn more about the HealthCert Professional Diploma program in Skin Cancer Medicine.
Dr Filanovsky describes his work in cutaneous surgery at Skin Care West in Canada which utilises a team-based approach combining dermatologists and family physicians. This model is developing popularity in Australia too, due to a shortage of dermatologists and a high prevalence of skin cancer.
Dr Filanovsky goes on to give a detailed explanation of how he uses the topical field treatment imiquimod in his practice, especially for the treatment of basal cell carcinoma (BCC).
He also speaks about the surgical options for treating BCCs, including excision guidelines and when the use of topical therapies is appropriate instead of surgical intervention.
Dr Filanovsky discusses the sites, lesion types and patient groups for which he recommends imiquimod.
He has made the following available for download:
You can also visit his website here.
Hear all this and much more in the full podcast above.
Listen to another podcast with Dr Gene Filanovsky: Topical 5 fluorouracil-calcipotriol compound for actinic keratosis
One comment on “[Podcast] Imiquimod for BCC”
Clearly cost of Imiquimod for Australian patients is a major factor. Especially rural patients where we see such huge numbers of Skin cancers. Also cost never seems to come into the Canadian model. We struggle to keep the doors open on our medicare rebates. Especially when there are serial procedures done at the same time because patients often need to travel distances to see us and are often frail and infirm.